Document ID: chunk:federal_register_of_legislation:F2022C00925:reg:9:p2
Version: federal_register_of_legislation:F2022C00925
Segment Type: reg
Provision Reference: reg 9 (pt 2/4)
Character Range: 8180–11255

1 - Dictionary.
(12)      having infection with human immunodeficiency virus or hepatitis C virus before the clinical onset of carotid artery disease;
(13)      having infection of the affected artery with a bacterial or fungal organism before the clinical onset of carotid artery disease;
(14)      having an autoimmune disease of the affected artery before the clinical onset of carotid artery disease;
            Note: Examples of autoimmune diseases that may cause carotid artery disease are ankylosing spondylitis, antiphospholipid syndrome, Behcet disease, inflammatory bowel disease, psoriatic arthropathy, rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
(15)      having a neoplasm infiltrating the affected segment of the artery at the time of the clinical onset of carotid artery disease;
(16)      for dissection of the internal carotid artery only, being within the 30 days postpartum at the time of the clinical onset of carotid artery disease;
(17)      for aneurysm, dissection or arteriovenous fistula only, having trauma to the affected segment of the artery before the clinical onset of carotid artery disease;
            Note: trauma to the affected segment of the artery is defined in the Schedule 1 - Dictionary.
(18)      for dissection only, having trauma to the neck or the base of the skull within the three months before the clinical onset of carotid artery disease;
            Note: trauma to the neck or the base of the skull is defined in the Schedule 1 - Dictionary.
(19)      for aneurysm or dissection of the common or internal carotid artery only, taking a drug from the specified list of drugs within the four days before the clinical onset of carotid artery disease;
            Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(20)      having hypertension before the clinical worsening of carotid artery disease;
(21)      having diabetes mellitus before the clinical worsening of carotid artery disease;
(22)      having dyslipidaemia before the clinical worsening of carotid artery disease;
            Note: dyslipidaemia is defined in the Schedule 1 - Dictionary.
(23)      where smoking has not permanently ceased, having smoked at least one pack-year of tobacco products before the clinical worsening of carotid artery disease;
            Note: one pack-year is defined in the Schedule 1 - Dictionary.
(24)      where smoking has permanently ceased before the clinical worsening of carotid artery disease:
(a)          having smoked at least five pack-years of tobacco products; or
(b)          having smoked at least one pack-year but less than five pack-years of tobacco products, and the clinical worsening of carotid artery disease has occurred within 20 years of smoking cessation;
             Note: one pack-year is defined in the Schedule 1 - Dictionary.
(25)      where exposure to second-hand smoke has not permanently ceased, being exposed to second-hand smoke for at least 1,000 hours before the clinical worsening of carotid artery disease;
            Note: being